[Long-term therapy of liver diseases].
D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003348:Cortisone / Q000627:therapeutic use; D004035:Diet Therapy; D005234:Fatty Liver / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006432:Hemochromatosis / Q000188:drug therapy; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy* / Q000628:therapy; D008109:Liver Diseases, Parasitic / Q000188:drug therapy; D008113:Liver Neoplasms / Q000188:drug therapy; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010396:Penicillamine / Q000627:therapeutic use; D011164:Porphyrias / Q000188:drug therapy
D045930:Anabolic Agents; D007166:Immunosuppressive Agents; D010396:Penicillamine; D005472:Fluorouracil; D003348:Cortisone
Longzeittherapie von Leberkrankheiten.